English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Calithera Biosciences
Carol Ostrow
| Dec 26, 2017
Calithera presents results of breast cancer treatment study
Ruth de Jauregui
| Jun 17, 2017
Bristol-Myers Squibb, Calithera Biosciences to evaluate Opdivo, CB-839 in treating non-small cell lung cancer
Robert Hadley
| Jun 16, 2017
Calithera says trials indicate new drug can inhibit growth of solid tumors
Trending
+
Marketing
Patient Daily
| Sep 17, 2025
Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+
Pharmaceuticals
Patient Daily
| Sep 23, 2025
Wall Street Journal editorial board alleges hospitals misuse 340B program
+
Regulatory
Patient Daily
| Sep 17, 2025
PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'
+
Pharmaceuticals
Patient Daily
| Sep 22, 2025
Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
